2020 Form 10-K Financial Statement

#000035501920000051 Filed on October 01, 2020

View on sec.gov

Income Statement

Concept 2020 2019 Q2 2019
Revenue $85.69M $22.48M $87.19M
YoY Change -1.72% 6.84% 6.96%
Cost Of Revenue $43.30M $11.24M $44.00M
YoY Change -1.59% 5.74% 5757.13%
Gross Profit $42.40M $11.24M $43.20M
YoY Change -1.85% 7.97% -46.51%
Gross Profit Margin 49.48% 50.0% 49.55%
Selling, General & Admin $26.72M $6.790M $19.26M
YoY Change 38.71% 29.83% 6.27%
% of Gross Profit 63.01% 60.41% 44.59%
Research & Development $2.025M $440.0K $1.812M
YoY Change 11.75% -12.0% 3.22%
% of Gross Profit 4.78% 3.91% 4.2%
Depreciation & Amortization $3.909M $990.0K $3.836M
YoY Change 1.88% 4.21% -1.62%
% of Gross Profit 9.22% 8.81% 8.88%
Operating Expenses $28.74M $7.240M $21.07M
YoY Change 36.39% 26.57% 6.0%
Operating Profit $13.66M $4.000M $22.13M
YoY Change -38.27% -14.71% -63.66%
Interest Expense $74.32K $130.0K $98.64K
YoY Change -24.65% 116.67% -161.62%
% of Operating Profit 0.54% 3.25% 0.45%
Other Income/Expense, Net $70.77K $0.00 $1.065K
YoY Change 6545.16% -100.0% -124.94%
Pretax Income $14.15M $4.140M $22.52M
YoY Change -37.17% -13.03% 13.83%
Income Tax $2.445M -$1.820M $2.006M
% Of Pretax Income 17.28% -43.96% 8.91%
Net Earnings $8.240M $4.580M $15.32M
YoY Change -46.2% -53.46% -27.85%
Net Earnings / Revenue 9.62% 20.37% 17.57%
Basic Earnings Per Share $1.28 $2.41
Diluted Earnings Per Share $1.171M $667.6K $2.217M
COMMON SHARES
Basic Shares Outstanding 6.444M shares 6.354M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2020 2019 Q2 2019
SHORT-TERM ASSETS
Cash & Short-Term Investments $36.80M $29.00M $29.00M
YoY Change 26.9% 47.96% 47.96%
Cash & Equivalents $36.80M $13.88M $13.90M
Short-Term Investments $0.00 $15.10M $15.10M
Other Short-Term Assets $1.800M $1.500M $1.500M
YoY Change 20.0% 15.38% 15.38%
Inventory $1.800M $2.300M $2.300M
Prepaid Expenses
Receivables $54.80M $51.70M $51.70M
Other Receivables $700.0K $600.0K $600.0K
Total Short-Term Assets $95.90M $85.09M $85.10M
YoY Change 12.69% 26.88% 26.83%
LONG-TERM ASSETS
Property, Plant & Equipment $54.10M $16.99M $17.00M
YoY Change 218.24% 2.99% 3.03%
Goodwill $3.985M
YoY Change 0.0%
Intangibles $4.756M
YoY Change -15.1%
Long-Term Investments
YoY Change
Other Assets $19.50M $22.10M $22.10M
YoY Change -11.76% -7.92% -7.92%
Total Long-Term Assets $84.40M $48.47M $48.50M
YoY Change 74.02% -5.39% -5.27%
TOTAL ASSETS
Total Short-Term Assets $95.90M $85.09M $85.10M
Total Long-Term Assets $84.40M $48.47M $48.50M
Total Assets $180.3M $133.6M $133.6M
YoY Change 34.96% 12.9% 12.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.000M $1.861M $1.900M
YoY Change 5.26% 43.14% 46.15%
Accrued Expenses $10.80M $7.000M $7.000M
YoY Change 54.29% -5.41% -5.41%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $200.0K $313.6K $0.00
YoY Change -8.92%
Total Short-Term Liabilities $18.70M $14.09M $14.10M
YoY Change 32.62% -3.27% -3.42%
LONG-TERM LIABILITIES
Long-Term Debt $2.100M $300.0K $300.0K
YoY Change 600.0% 0.0% 0.0%
Other Long-Term Liabilities $33.00M $800.0K $800.0K
YoY Change 4025.0% -20.0% -20.0%
Total Long-Term Liabilities $35.10M $1.358M $1.100M
YoY Change 3090.91% -10.04% -15.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.70M $14.09M $14.10M
Total Long-Term Liabilities $35.10M $1.358M $1.100M
Total Liabilities $54.10M $15.45M $17.60M
YoY Change 207.39% -3.91% -10.2%
SHAREHOLDERS EQUITY
Retained Earnings -$64.46M
YoY Change -19.2%
Common Stock $181.1M
YoY Change 1.09%
Preferred Stock
YoY Change
Treasury Stock (at cost) $675.4K
YoY Change -200.06%
Treasury Stock Shares
Shareholders Equity $126.2M $116.0M $116.0M
YoY Change
Total Liabilities & Shareholders Equity $180.3M $133.6M $133.6M
YoY Change 34.96% 12.89% 12.93%

Cashflow Statement

Concept 2020 2019 Q2 2019
OPERATING ACTIVITIES
Net Income $8.240M $4.580M $15.32M
YoY Change -46.2% -53.46% -27.85%
Depreciation, Depletion And Amortization $3.909M $990.0K $3.836M
YoY Change 1.88% 4.21% -1.62%
Cash From Operating Activities $20.40M $6.320M $19.45M
YoY Change 4.91% 2.93% 3.78%
INVESTING ACTIVITIES
Capital Expenditures $7.523M -$320.0K $3.355M
YoY Change 124.2% 45.45% -220.79%
Acquisitions
YoY Change
Other Investing Activities $15.06M -$90.00K -$15.09M
YoY Change -199.8% 50.0% 25050.0%
Cash From Investing Activities $7.422M -$420.0K -$18.58M
YoY Change -139.95% 50.0% 530.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$4.905M -1.790M -$6.622M
YoY Change -25.93% 9.15% 5.1%
NET CHANGE
Cash From Operating Activities $20.40M 6.320M $19.45M
Cash From Investing Activities $7.422M -420.0K -$18.58M
Cash From Financing Activities -$4.905M -1.790M -$6.622M
Net Change In Cash $22.92M 4.110M -$5.752M
YoY Change -498.49% -2.61% -160.58%
FREE CASH FLOW
Cash From Operating Activities $20.40M $6.320M $19.45M
Capital Expenditures $7.523M -$320.0K $3.355M
Free Cash Flow $12.88M $6.640M $16.09M
YoY Change -19.97% 4.4% -25.21%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 us-gaap Net Income Loss
NetIncomeLoss
15317131 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
8240205 usd
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6354103 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6443713 shares
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.41
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.28
CY2019 FONR Management And Other Fees Related Medical Practices Net
ManagementAndOtherFeesRelatedMedicalPracticesNet
9354864 usd
CY2020 FONR Management And Other Fees Related Medical Practices Net
ManagementAndOtherFeesRelatedMedicalPracticesNet
10166694 usd
CY2019 FONR Costs Related To Service And Repair Fees Related Parties
CostsRelatedToServiceAndRepairFeesRelatedParties
40603 usd
CY2020 FONR Costs Related To Service And Repair Fees Related Parties
CostsRelatedToServiceAndRepairFeesRelatedParties
37298 usd
CY2019 FONR Costs Related To Management And Other Fees Related Medical Practices
CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
5947055 usd
CY2020 FONR Costs Related To Management And Other Fees Related Medical Practices
CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
5951189 usd
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1812347 usd
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2025376 usd
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19261755 usd
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
26717345 usd
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
65058695 usd
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
72039546 usd
CY2019 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
22134192 usd
CY2020 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
13650916 usd
CY2019 us-gaap Investment Income Net
InvestmentIncomeNet
482573 usd
CY2020 us-gaap Investment Income Net
InvestmentIncomeNet
502145 usd
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22519194 usd
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14149511 usd
CY2019 us-gaap Profit Loss
ProfitLoss
20513674 usd
CY2020 us-gaap Profit Loss
ProfitLoss
11704733 usd
CY2019 FONR Service And Repair Fees Related Parties Net
ServiceAndRepairFeesRelatedPartiesNet
110000 usd
CY2020 FONR Service And Repair Fees Related Parties Net
ServiceAndRepairFeesRelatedPartiesNet
110000 usd
CY2019 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
10789308 usd
CY2020 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
10880265 usd
CY2019Q4 dei Entity Public Float
EntityPublicFloat
123000000 usd
CY2019 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
1990380 usd
CY2020 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
usd
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1065 usd
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
70771 usd
CY2020 dei Entity Registrant Name
EntityRegistrantName
FONAR CORP
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0000355019
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2019 FONR Product Sales Net
ProductSalesNet
1751221 usd
CY2020 FONR Product Sales Net
ProductSalesNet
297613 usd
CY2019 FONR Service And Repair Fees Net
ServiceAndRepairFeesNet
8152173 usd
CY2020 FONR Service And Repair Fees Net
ServiceAndRepairFeesNet
8055490 usd
CY2019 FONR Patient Fee Revenue Net Of Contractual Allowances And Discounts
PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
24207536 usd
CY2020 FONR Patient Fee Revenue Net Of Contractual Allowances And Discounts
PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
22495260 usd
CY2019 FONR Management And Other Fees Net
ManagementAndOtherFeesNet
43617093 usd
CY2020 FONR Management And Other Fees Net
ManagementAndOtherFeesNet
44565405 usd
CY2019 FONR Costs Related To Product Sales
CostsRelatedToProductSales
778734 usd
CY2020 FONR Costs Related To Product Sales
CostsRelatedToProductSales
745375 usd
CY2019 FONR Costs Related To Service And Repair Fees
CostsRelatedToServiceAndRepairFees
3009097 usd
CY2020 FONR Costs Related To Service And Repair Fees
CostsRelatedToServiceAndRepairFees
2731397 usd
CY2019 FONR Costs Related To Management And Other Fees
CostsRelatedToManagementAndOtherFees
23419796 usd
CY2020 FONR Costs Related To Management And Other Fees
CostsRelatedToManagementAndOtherFees
22951301 usd
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 dei Entity Small Business
EntitySmallBusiness
true
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2019 us-gaap Revenues
Revenues
87192887 usd
CY2020 us-gaap Revenues
Revenues
85690462 usd
CY2020 dei Entity File Number
EntityFileNumber
0-10248
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
118112103 usd
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
126242216 usd
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
102234471 usd
CY2019 us-gaap Interest Expense
InterestExpense
98636 usd
CY2020 us-gaap Interest Expense
InterestExpense
74321 usd
CY2019 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
5196543 usd
CY2020 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3464528 usd
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13882013 usd
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36802342 usd
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19633742 usd
CY2019 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5751729 usd
CY2020 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
22920329 usd
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6621512 usd
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4904847 usd
CY2019 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
6600000 usd
CY2020 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
5565000 usd
CY2019 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
9213 usd
CY2020 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
usd
CY2019 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
usd
CY2020 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
5618089 usd
CY2019 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
30725 usd
CY2020 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
4957936 usd
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18578665 usd
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7422413 usd
CY2019 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
128393 usd
CY2020 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
117522 usd
CY2019 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
15094816 usd
CY2020 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
usd
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3355456 usd
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7522997 usd
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
19448448 usd
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20402763 usd
CY2019 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-134880 usd
CY2020 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
usd
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
11943 usd
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
115855 usd
CY2019 us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
-59544 usd
CY2020 us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
55928 usd
CY2019 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-980394 usd
CY2020 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
3556437 usd
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
560977 usd
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
104032 usd
CY2019 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-329 usd
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
161350 usd
CY2019 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
79641 usd
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
133287 usd
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
366786 usd
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-149396 usd
CY2019 us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
438472 usd
CY2020 us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
-372277 usd
CY2019 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
12689 usd
CY2020 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-28889 usd
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6134095 usd
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10797456 usd
CY2019 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1954745 usd
CY2020 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1990380 usd
CY2019 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
usd
CY2020 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1005560 usd
CY2019 us-gaap Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
usd
CY2020 us-gaap Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
528815 usd
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1755520 usd
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2118829 usd
CY2019 FONR Provision For Bad Debts
ProvisionForBadDebts
-978730 usd
CY2020 FONR Provision For Bad Debts
ProvisionForBadDebts
5695420 usd
CY2019 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
3836491 usd
CY2020 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
3908648 usd
CY2019 FONR Stock Issued To Employees Under Stock Bonus Plans Value
StockIssuedToEmployeesUnderStockBonusPlansValue
1954745 usd
CY2020 FONR Stock Issued To Employees Under Stock Bonus Plans Value
StockIssuedToEmployeesUnderStockBonusPlansValue
1990380 usd
CY2019 FONR Payments On Notes Receivable From Employee Stockholders
PaymentsOnNotesReceivableFromEmployeeStockholders
9213 usd
CY2020 FONR Payments On Notes Receivable From Employee Stockholders
PaymentsOnNotesReceivableFromEmployeeStockholders
usd
CY2019 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
6600000 usd
CY2020 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
5565000 usd
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Use of Estimates</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities in the consolidated financial statements and accompanying notes. The most significant estimates relate to receivable allowances, intangible assets, income taxes and related tax asset valuation allowances, useful lives of property and equipment, contingencies, revenue recognition and the assessment of litigation. In addition, healthcare industry reforms and reimbursement practices will continue to impact the Company's operations and the determination of contractual and other allowance estimates. Actual results could differ from those estimates.</p>
CY2020 us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Customer Advances</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash advances and progress payments received on sales orders are reflected as customer advances until such time as revenue recognition occurs.</p>
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Concentration of Credit Risk</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash: The Company maintains its cash and cash equivalents with various financial institutions, which exceed federally insured limits throughout the year. At June 30, 2020, the Company had cash on deposit of approximately $33,444,000 in excess of federally insured limits of $250,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Related Parties: Net revenues from related parties accounted for approximately 12% and 11% of the consolidated net revenues for the years ended June 30, 2020 and 2019, respectively. Net management fee receivables from the related party medical practices accounted for approximately 13% and 13% of the consolidated accounts receivable for the years ended June 30, 2020 and 2019, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">See Note 3 regarding the Company&#8217;s concentrations in the healthcare industry.</p>
CY2020 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Reclassifications</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain prior year amounts have been reclassified to conform to the current year presentation. The reclassifications did not have any effect on reported net income for any periods presented.</p>
CY2020 FONR Estimated Useful Life In Years For Property And Equipment
EstimatedUsefulLifeInYearsForPropertyAndEquipment
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The estimated useful lives in years are generally as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">Diagnostic equipment</font></td> <td style="text-align: right"><font style="font-size: 10pt">5&#8211;13</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">Research, development and demonstration equipment</font></td> <td style="text-align: right"><font style="font-size: 10pt">3-7</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">Machinery and equipment</font></td> <td style="text-align: right"><font style="font-size: 10pt">2-7</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">Furniture and fixtures</font></td> <td style="text-align: right"><font style="font-size: 10pt">3-9</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">Leasehold improvements</font></td> <td style="text-align: right"><font style="font-size: 10pt">2&#8211;10</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 90%; padding-left: 5.4pt"><font style="font-size: 10pt">Building</font></td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">28</font></td></tr> </table>
CY2020 us-gaap Revenue Recognition Allowances
RevenueRecognitionAllowances
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company&#8217;s patient fee revenues, net of contractual allowances and discounts less the provision for bad debts for the years ended June 30, 2020 and 2019 are summarized in the following table.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="7" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">For the Years Ended June 30</font></td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top; width: 62%; padding-left: 27.9pt; text-indent: -20pt"><font style="font-size: 10pt">Commercial Insurance/ Managed Care</font></td> <td style="vertical-align: bottom; width: 3%">&#160;</td> <td style="vertical-align: bottom; width: 1%"><font style="font-size: 10pt">$</font></td> <td style="vertical-align: bottom; width: 15%; text-align: right"><font style="font-size: 10pt">4,545,987</font></td> <td style="vertical-align: bottom; width: 1%">&#160;</td> <td style="vertical-align: bottom; width: 1%">&#160;</td> <td style="vertical-align: bottom; width: 1%"><font style="font-size: 10pt">$</font></td> <td style="vertical-align: bottom; width: 15%; text-align: right"><font style="font-size: 10pt">5,218,656</font></td> <td style="vertical-align: bottom; width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 27.9pt; text-indent: -20pt"><font style="font-size: 10pt">Medicare/Medicaid</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,038,288</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,172,543</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-indent: 10pt"><font style="font-size: 10pt">Workers' Compensation/Personal Injury</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">16,028,737</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">16,790,025</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 27.9pt; text-indent: -20pt"><font style="font-size: 10pt">Other</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid; padding-left: 27.9pt">&#160;</td> <td style="border-bottom: black 1pt solid; padding-left: 27.9pt; text-align: right"><font style="font-size: 10pt">882,248</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-left: 27.9pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">1,026,312</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 27.9pt; text-indent: -20pt"><font style="font-size: 10pt">Net Patient Fee Revenue</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; padding-left: 27.9pt"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; padding-left: 27.9pt; text-align: right"><font style="font-size: 10pt">22,495,260</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-left: 27.9pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">24,207,536</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table>
CY2020 FONR Export Product Sales
ExportProductSales
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The foreign product sales, as a percentage of product sales to unrelated parties, were made to customers in the following countries:</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="7" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">For the Years Ended June 30</font></td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 68%; padding-left: 5.4pt"><font style="font-size: 10pt">Canada</font></td> <td style="width: 3%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="width: 1%">&#160;</td> <td style="width: 3%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">.3</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">England</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">.3</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">Germany</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">20.2</font></td> <td><font style="font-size: 10pt">%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-size: 10pt">Puerto Rico</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt">&#160;</td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-left: 5.4pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">4.7</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt">&#160;</td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">20.2</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td> <td style="padding-left: 5.4pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">5.3</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td></tr> </table>
CY2020 FONR Export Service Revenues
ExportServiceRevenues
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Foreign service and repair fees, as a percentage of total service and repair fees, were provided principally to the following countries:</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="7" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">For the Years Ended June 30,</font></td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 68%; padding-left: 5.4pt"><font style="font-size: 10pt">Puerto Rico</font></td> <td style="width: 3%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">1.6</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td> <td style="width: 3%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">1.6</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">Switzerland</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.3</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.3</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">Germany</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1.5</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1.4</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">England</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.7</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.6</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">United Arab Emirates</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.3</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">Canada</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.3</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.4</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 5.4pt"><font style="font-size: 10pt">Greece</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.2</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.3</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-size: 10pt">Australia</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt">&#160;</td> <td style="border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">1.0</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-left: 5.4pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">1.0</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt">&#160;</td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">5.6</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td> <td style="padding-left: 5.4pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">5.9</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td></tr> </table>
CY2019Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
13882013 usd
CY2020Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
36802342 usd
CY2019Q2 us-gaap Short Term Investments
ShortTermInvestments
15094816 usd
CY2020Q2 us-gaap Short Term Investments
ShortTermInvestments
31884 usd
CY2019Q2 us-gaap Costs In Excess Of Billings On Uncompleted Contracts Or Programs
CostsInExcessOfBillingsOnUncompletedContractsOrPrograms
525110 usd
CY2020Q2 us-gaap Costs In Excess Of Billings On Uncompleted Contracts Or Programs
CostsInExcessOfBillingsOnUncompletedContractsOrPrograms
152833 usd
CY2019Q2 us-gaap Inventory Finished Goods And Work In Process
InventoryFinishedGoodsAndWorkInProcess
1798166 usd
CY2020Q2 us-gaap Inventory Finished Goods And Work In Process
InventoryFinishedGoodsAndWorkInProcess
1648770 usd
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1512917 usd
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1757499 usd
CY2019Q2 us-gaap Assets Current
AssetsCurrent
85088722 usd
CY2020Q2 us-gaap Assets Current
AssetsCurrent
95889532 usd
CY2019Q2 us-gaap Income Tax Receivable
IncomeTaxReceivable
600000 usd
CY2020Q2 us-gaap Income Tax Receivable
IncomeTaxReceivable
usd
CY2019Q2 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
20937747 usd
CY2020Q2 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
18809757 usd
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16985617 usd
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21364034 usd
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
usd
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
31392458 usd
CY2019Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
40530 usd
CY2020Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
108379 usd
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1861227 usd
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1965259 usd
CY2019Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
usd
CY2020Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1325870 usd
CY2019Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7577416 usd
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8185098 usd
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
usd
CY2019Q2 us-gaap Goodwill
Goodwill
3985397 usd
CY2020Q2 us-gaap Goodwill
Goodwill
3985397 usd
CY2019Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4755675 usd
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4109129 usd
CY2019Q2 us-gaap Other Assets
OtherAssets
1207052 usd
CY2020Q2 us-gaap Other Assets
OtherAssets
653132 usd
CY2019Q2 us-gaap Assets
Assets
133560210 usd
CY2020Q2 us-gaap Assets
Assets
180259380 usd
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3370149 usd
CY2019Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
usd
CY2020Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
74699 usd
CY2019Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3812115 usd
CY2020Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4105265 usd
CY2019Q2 us-gaap Customer Advances Current
CustomerAdvancesCurrent
798651 usd
CY2020Q2 us-gaap Customer Advances Current
CustomerAdvancesCurrent
854579 usd
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
14089939 usd
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
18663428 usd
CY2019Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
usd
CY2020Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2655605 usd
CY2019Q2 us-gaap Deferred Income Taxes And Other Liabilities Noncurrent
DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent
243267 usd
CY2020Q2 us-gaap Deferred Income Taxes And Other Liabilities Noncurrent
DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent
234106 usd
CY2019Q2 us-gaap Accounts Payable Related Parties Noncurrent
AccountsPayableRelatedPartiesNoncurrent
92663 usd
CY2020Q2 us-gaap Accounts Payable Related Parties Noncurrent
AccountsPayableRelatedPartiesNoncurrent
92663 usd
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
30104464 usd
CY2019Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
usd
CY2020Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1251171 usd
CY2019Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
273112 usd
CY2020Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
865416 usd
CY2019Q2 us-gaap Other Liabilities
OtherLiabilities
749126 usd
CY2020Q2 us-gaap Other Liabilities
OtherLiabilities
150311 usd
CY2019Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1358168 usd
CY2020Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
35353736 usd
CY2019Q2 us-gaap Liabilities
Liabilities
15448107 usd
CY2020Q2 us-gaap Liabilities
Liabilities
54017164 usd
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
181086517 usd
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
183076888 usd
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
115956378 usd
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
126186963 usd
CY2019Q2 us-gaap Minority Interest
MinorityInterest
2155725 usd
CY2020Q2 us-gaap Minority Interest
MinorityInterest
55253 usd
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
133560210 usd
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
180259380 usd
CY2019Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
600000 usd
CY2020Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
671185 usd
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-64455456 usd
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-56215251 usd
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2005520 usd
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2444778 usd
CY2019 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
usd
CY2020 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
159657 usd
CY2019 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
usd
CY2020 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
15062932 usd
CY2019Q2 us-gaap Treasury Stock Value
TreasuryStockValue
675390 usd
CY2020Q2 us-gaap Treasury Stock Value
TreasuryStockValue
675390 usd
CY2019 us-gaap Health Care Organization Patient Service Revenue Less Provision For Bad Debts
HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts
24207536 usd
CY2020 us-gaap Health Care Organization Patient Service Revenue Less Provision For Bad Debts
HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts
22495260 usd
CY2019 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
1557000 usd
CY2020 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
1870000 usd
CY2020Q2 FONR Management Agreements With Company Total Medical Practices
ManagementAgreementsWithCompanyTotalMedicalPractices
21 pure
CY2020Q2 FONR Scanners With Management Agreements With Company Owned By Related Party
ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty
3 pure
CY2020Q2 FONR Scanners With Management With Company Located In New York State
ScannersWithManagementWithCompanyLocatedInNewYorkState
18 pure
CY2019 us-gaap Advertising Expense
AdvertisingExpense
538000 usd
CY2020 us-gaap Advertising Expense
AdvertisingExpense
566000 usd
CY2019 FONR Shipping And Handling Expense
ShippingAndHandlingExpense
13695 usd
CY2020 FONR Shipping And Handling Expense
ShippingAndHandlingExpense
12056 usd
CY2019 FONR Number Of Shares Upon Conversion Of Class C Common Included In Diluted Eps For Common Shareholders
NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders
127504 shares
CY2020 FONR Number Of Shares Upon Conversion Of Class C Common Included In Diluted Eps For Common Shareholders
NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders
127504 shares
CY2020Q2 us-gaap Cash
Cash
33444000 usd
CY2020Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
22700000 usd
CY2020Q2 us-gaap Contract Receivable Due One To Two Years
ContractReceivableDueOneToTwoYears
821535 usd
CY2020Q2 us-gaap Contract Receivable Due Two To Three Years
ContractReceivableDueTwoToThreeYears
744660 usd
CY2020Q2 us-gaap Contract Receivable Due Three To Four Years
ContractReceivableDueThreeToFourYears
744660 usd
CY2020Q2 us-gaap Contract Receivable Due Four To Five Years
ContractReceivableDueFourToFiveYears
344750 usd
CY2020Q2 us-gaap Accounts Receivable Billed For Long Term Contracts Or Programs
AccountsReceivableBilledForLongTermContractsOrPrograms
2655605 usd
CY2019 FONR Total Facilities Owned Or Managed At Beginning Of Year
TotalFacilitiesOwnedOrManagedAtBeginningOfYear
26
CY2020 FONR Total Facilities Owned Or Managed At Beginning Of Year
TotalFacilitiesOwnedOrManagedAtBeginningOfYear
26
CY2019 FONR Managed Facilities Added Acquisition
ManagedFacilitiesAddedAcquisition
CY2020 FONR Managed Facilities Added Acquisition
ManagedFacilitiesAddedAcquisition
CY2019 FONR Managed Facilities Added By Internal Development
ManagedFacilitiesAddedByInternalDevelopment
CY2020 FONR Managed Facilities Added By Internal Development
ManagedFacilitiesAddedByInternalDevelopment
CY2019 FONR Managed Facilities Closed During Year
ManagedFacilitiesClosedDuringYear
CY2020 FONR Managed Facilities Closed During Year
ManagedFacilitiesClosedDuringYear
-1
CY2019 FONR Total Facilities Owned Or Managed At End Of Year
TotalFacilitiesOwnedOrManagedAtEndOfYear
26
CY2020 FONR Total Facilities Owned Or Managed At End Of Year
TotalFacilitiesOwnedOrManagedAtEndOfYear
25
CY2019 FONR Percentage Of Pcs Net Revenue Derived From Nofault And Personal Injury Protection Claims
PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims
0.67 pure
CY2020 FONR Percentage Of Pcs Net Revenue Derived From Nofault And Personal Injury Protection Claims
PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims
0.66 pure
CY2019 FONR Percentage Of Consolidated Net Revenue From Management Fees
PercentageOfConsolidatedNetRevenueFromManagementFees
0.11 pure
CY2020 FONR Percentage Of Consolidated Net Revenue From Management Fees
PercentageOfConsolidatedNetRevenueFromManagementFees
0.12 pure
CY2019Q2 FONR Costs Incurred On Uncompleted Contracts
CostsIncurredOnUncompletedContracts
448437 usd
CY2020Q2 FONR Costs Incurred On Uncompleted Contracts
CostsIncurredOnUncompletedContracts
448437 usd
CY2019Q2 FONR Estimated Earnings
EstimatedEarnings
1088675 usd
CY2020Q2 FONR Estimated Earnings
EstimatedEarnings
309248 usd
CY2019Q2 FONR Costs And Estimated Earnings On Uncompleted Contracts
CostsAndEstimatedEarningsOnUncompletedContracts
1537112 usd
CY2020Q2 FONR Costs And Estimated Earnings On Uncompleted Contracts
CostsAndEstimatedEarningsOnUncompletedContracts
757685 usd
CY2019Q2 FONR Billings To Date
BillingsToDate
1012002 usd
CY2020Q2 FONR Billings To Date
BillingsToDate
604852 usd
CY2019Q2 us-gaap Other Inventory Supplies
OtherInventorySupplies
1639777 usd
CY2020Q2 us-gaap Other Inventory Supplies
OtherInventorySupplies
1544036 usd
CY2019Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
158389 usd
CY2020Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
104734 usd
CY2019Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
43850187 usd
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
51373184 usd
CY2019Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
26864570 usd
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
30009150 usd
CY2019Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19869046 usd
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19986568 usd
CY2019Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15113371 usd
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15877439 usd
CY2019Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
4755675 usd
CY2020Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
4109129 usd
CY2018Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
5601656 usd
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
370631 usd
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
369241 usd
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
372700 usd
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
372399 usd
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
359378 usd
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
2264780 usd
CY2019 FONR Amounts Capitalized
AmountsCapitalized
128393 usd
CY2020 FONR Amounts Capitalized
AmountsCapitalized
117522 usd
CY2019 FONR Software Or Patents Written Off
SoftwareOrPatentsWrittenOff
usd
CY2020 FONR Software Or Patents Written Off
SoftwareOrPatentsWrittenOff
usd
CY2019 us-gaap Adjustment For Amortization
AdjustmentForAmortization
-974374 usd
CY2020 us-gaap Adjustment For Amortization
AdjustmentForAmortization
-764068 usd
CY2020 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P12Y
CY2019Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
313642 usd
CY2019 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
250000 usd
CY2020 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
513204 usd
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
250000 usd
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
325949 usd
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1685299 usd
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1953349 usd
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
70221 usd
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
165480 usd
CY2020Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
973795 usd
CY2020Q2 FONR Book Value Of Building
BookValueOfBuilding
447448 usd
CY2019Q2 us-gaap Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months
LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths
108379 usd
CY2019Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
178166 usd
CY2019Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
180972 usd
CY2019Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour
183919 usd
CY2019Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive
187154 usd
CY2019Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal After Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive
135205 usd
CY2019Q2 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
973795 usd
CY2019 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
usd
CY2020 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
-187255 usd
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.04 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.04 pure
CY2019 us-gaap Effective Income Tax Rate Reconciliation Minority Interest Income Expense
EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
-0.058 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Minority Interest Income Expense
EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
-0.061 pure
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.035 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.002 pure
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.026 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.003 pure
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.042 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.021 pure
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.089 pure
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.173 pure
CY2019Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
3011480 usd
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
3946801 usd
CY2019Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
861345 usd
CY2020Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
693833 usd
CY2019Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
16448054 usd
CY2020Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
13720637 usd
CY2019Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
4601801 usd
CY2020Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
4647217 usd
CY2019Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
65081 usd
CY2020Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
69940 usd
CY2019Q2 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
192133 usd
CY2020Q2 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
168371 usd
CY2019Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
25179894 usd
CY2020Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
23246799 usd
CY2019Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4242147 usd
CY2020Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4437042 usd
CY2019Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
20937747 usd
CY2020Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
18809757 usd
CY2019Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
243267 usd
CY2020Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
234106 usd
CY2020Q2 us-gaap Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Policyholders Surplus
DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus
234106 usd
CY2020Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
54883000 usd
CY2019Q2 us-gaap Deferred Taxes Business Combination Valuation Allowance Allocated To Contributed Capital
DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital
2350000 usd
CY2020Q2 us-gaap Deferred Taxes Business Combination Valuation Allowance Allocated To Contributed Capital
DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital
195000 usd
CY2020 FONR Reimbursement Of Alternative Minimum Tax Credits Description
ReimbursementOfAlternativeMinimumTaxCreditsDescription
Company is allowing a full reimbursement of $1,342,370 of tax credits relating to the alternative minimum tax credits. The Company received the first half payment in June 2020. The balance of alternative minimum tax credits of $671,185 was received in July 2020. Previously, these credits were to be refunded over a 3 year period.
CY2020Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
4440000 usd
CY2020Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
4437000 usd
CY2020Q2 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
208000 usd
CY2019Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
3897833 usd
CY2020Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
4491941 usd
CY2019Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
145029 usd
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
442802 usd
CY2019Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1671488 usd
CY2020Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1353200 usd
CY2019Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
125567 usd
CY2020Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
112867 usd
CY2019Q2 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
105000 usd
CY2020Q2 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
120000 usd
CY2019Q2 us-gaap Self Insurance Reserve
SelfInsuranceReserve
67825 usd
CY2020Q2 us-gaap Self Insurance Reserve
SelfInsuranceReserve
86504 usd
CY2019Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
1054134 usd
CY2020Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
877787 usd
CY2019Q2 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
510540 usd
CY2020Q2 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
699997 usd
CY2019 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
4688000 usd
CY2020 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
5136000 usd
FONR Property Tax Abatement
PropertyTaxAbatement
440000 usd
FONR Property Tax Abatement From Suffolk County Ida
PropertyTaxAbatementFromSuffolkCountyIda
0.5 pure
CY2019 us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
0 usd
CY2020 us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
0 usd
CY2020 FONR Stipulation Agreement With Creditors
StipulationAgreementWithCreditors
90619 usd
CY2020 FONR Average Monthly Payment For Stipulation Agreements
AverageMonthlyPaymentForStipulationAgreements
15859 usd
CY2020Q2 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
1353000 usd
CY2020Q2 FONR Recorded Sales Tax Obligations Interest And Penalties
RecordedSalesTaxObligationsInterestAndPenalties
832000 usd
CY2019Q2 us-gaap Liability For Claims And Claims Adjustment Expense Disability Accident And Health
LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth
68000 usd
CY2020Q2 us-gaap Liability For Claims And Claims Adjustment Expense Disability Accident And Health
LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth
87000 usd
CY2020 FONR Stoploss Umbrella Policy With3 Rd Paryinsurer To Limit Maximum Potential Liability For Individual Claims
StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims
110000 usd
CY2019 us-gaap Interest Paid
InterestPaid
165172 usd
CY2020 us-gaap Interest Paid
InterestPaid
137200 usd
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
304575 usd
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
228204 usd
CY2019 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1954744 usd
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1990380 usd
CY2019 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
69971 shares
CY2020 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
89981 shares
CY2019 FONR Intersegment Net Revenues
IntersegmentNetRevenues
907084 usd
CY2020 FONR Intersegment Net Revenues
IntersegmentNetRevenues
875000 usd
CY2019 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
22134192 usd
CY2020 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
13650916 usd
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3836491 usd
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3908648 usd
CY2019Q2 us-gaap Assets Net
AssetsNet
133560210 usd
CY2020Q2 us-gaap Assets Net
AssetsNet
180283510 usd
CY2019 FONR Foreign Product Sales
ForeignProductSales
0.053 pure
CY2020 FONR Foreign Product Sales
ForeignProductSales
0.202 pure
CY2019 FONR Foreign Service And Repair Fees
ForeignServiceAndRepairFees
0.059 pure
CY2020 FONR Foreign Service And Repair Fees
ForeignServiceAndRepairFees
0.056 pure
CY2019 FONR Export Sales Of Medical Equipment Percentage
ExportSalesOfMedicalEquipmentPercentage
0.053 pure
CY2020 FONR Export Sales Of Medical Equipment Percentage
ExportSalesOfMedicalEquipmentPercentage
0.202 pure
CY2019 FONR Foreign Revenues Of Service And Repair Of Medical Equipment Percentage
ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage
0.059 pure
CY2020 FONR Foreign Revenues Of Service And Repair Of Medical Equipment Percentage
ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage
0.056 pure
CY2019 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
3483849 usd
CY2020 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
7422413 usd
CY2020Q2 FONR Accounts Receivable Service And Repair Fees
AccountsReceivableServiceAndRepairFees
4312999 usd
CY2020 FONR Capital Stock And Options Disclosure Textblock
CapitalStockAndOptionsDisclosureTextblock
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">NOTE 8 - CAPITAL STOCK</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Common Stock</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Cash dividends payable on the common stock shall, in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend payable on shares of Class B common stock and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common stock.</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Class B Common Stock</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Class B common stock is convertible into shares of common stock on a one-for-one basis. Class B common stock has 10 votes per share. There were 146 of such shares outstanding at June 30, 2020 and 2019.</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Class C Common Stock</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On April 3, 1995, the stockholders ratified a proposal creating a new Class C common stock and authorized the exchange offering of three shares of Class C common stock for each share of the Company's outstanding Class B common stock. The Class C common stock has 25 votes per share, as compared to 10 votes per share for the Class B common stock and one vote per share for the common stock. The Class C common stock was offered on a three-for-one basis to the holders of the Class B common stock. Although having greater voting power, each share of Class C common stock has only one-third of the rights of a share of Class B common stock to dividends and distributions. Class C common stock is convertible into shares of common stock on a three-for-one basis.</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Class A Non-Voting Preferred Stock</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On April 3, 1995, the stockholders ratified a proposal consisting of the creation of a new class of Class A non-voting preferred stock with special dividend rights and the declaration of a stock dividend on the Company's common stock consisting of one share of Class A non-voting preferred stock for every five shares of common stock. The stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued pursuant to such stock dividend approximates 313,000 shares.</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Class A non-voting preferred stock is entitled to a special dividend equal to 3-1/4% of first $10 million, 4-1/2% of next $20 million and 5-1/2% on amounts in excess of $30 million of the amount of any cash awards or settlements received by the Company in connection with the enforcement of five of the Company's patents in its patent lawsuits, less the revised special dividend payable on the common stock with respect to one of the Company's patents.</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Class A non-voting preferred stock participates on an equal per share basis with the common stock in any dividends declared and ranks equally with the common stock on distribution rights, liquidation rights and other rights and preferences (other than the voting rights).</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Stock Bonus Plans</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><font style="font: normal 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><font style="font: normal 10pt Times New Roman, Times, Serif">On April 23, 2010, the Board approved the 2010 Stock Bonus Plan. The plan entitles the Company to reserve 2,000,000 shares of common stock. On August 10, 2010, the Company filed Form S-8 to register the 2,000,000 shares. As of June 30, 2020, 556,924 shares of common stock of FONAR were available for future grant under this plan. For the years ended June 30, 2020 and 2019, 89,981 and 69,971 shares were issued respectively, of which $0 and $1,990,380 were expensed and included in selling, general and administrative expenses for the years ended June 30, 2020 and 2019, respectively.</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Options</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company had stock option plans, which provide for the awarding of incentive and non-qualified stock options to employees, directors and consultants who may contribute to the success of the Company. The options granted vest either immediately or ratably over a period of time from the date of grant, typically three or four years, at a price determined by the Board of Directors or a committee of the Board of Directors, generally the fair value of the Company's common stock at the date of grant. The options must be exercised within ten years from the date of grant.</font></p>
CY2020 FONR Litigation Settelement Description
LitigationSettelementDescription
In September 2020, the Company entered into a settlement agreement with an unrelated third party for a claim made during March 2018 which was scheduled for arbitration. The settlement was for $1.2 million of which $900,000 is to be paid by the Company’s insurance with the remaining $315,000 to be paid by the Company. The $315,000 is included in other current liabilities as of June 30, 2020.
CY2020 FONR Receivable From Landlord For Tenant Improvements
ReceivableFromLandlordForTenantImprovements
202268 usd
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
33300000 usd
CY2019Q2 FONR Account Receivable Related Parties
AccountReceivableRelatedParties
usd
CY2019Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
20694480 usd
CY2020Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
18575651 usd
CY2019Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
243267 usd
CY2020Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
234106 usd
CY2019Q2 FONR Accounts Receivable Service And Repair Fees
AccountsReceivableServiceAndRepairFees
3736662 usd
CY2020Q2 FONR Account Receivable Related Parties
AccountReceivableRelatedParties
5988 usd
CY2019Q2 FONR Medical Receivable
MedicalReceivable
15728935 usd
CY2020Q2 FONR Medical Receivable
MedicalReceivable
16171782 usd
CY2019Q2 FONR Management And Other Fees Non Related Parties
ManagementAndOtherFees_NonRelatedParties
25709489 usd
CY2020Q2 FONR Management And Other Fees Non Related Parties
ManagementAndOtherFees_NonRelatedParties
27437768 usd
CY2019Q2 FONR Managment And Other Fees Receivable Related Medical Practices Net Allowances
ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
6500614 usd
CY2020Q2 FONR Managment And Other Fees Receivable Related Medical Practices Net Allowances
ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
6896482 usd
CY2019Q2 FONR Accounts Receivable Net Long Term
AccountsReceivableNetLongTerm
usd
CY2020Q2 FONR Accounts Receivable Net Long Term
AccountsReceivableNetLongTerm
2730071 usd
CY2020 us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
1350000 usd
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
5135604 usd
CY2020 FONR Depreciation Of Leased Equipment
DepreciationOfLeasedEquipment
usd
CY2020 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
usd
CY2020 FONR Finance Lease Cost
FinanceLeaseCost
usd
CY2020 FONR Operating Cash Flows From Operating Leases
OperatingCashFlowsFromOperatingLeases
4170977 usd
CY2020 FONR Rightofuse Equipment Assets Obtained In Exchange For Lease Obiligations Operating Leases
RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases
34786611 usd
CY2020 FONR Rightofuse Equipment Assets Obtained In Exchange For Lease Obiligations Financing Leases
RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsFinancingLeases
1325871 usd
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
5078892 usd
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4826934 usd
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4787845 usd
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4501027 usd
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
4445344 usd
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
19607295 usd
CY2020Q2 FONR Present Value Discount
PresentValueDiscount
9772724 usd
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
33474613 usd
CY2020Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
122172 usd
CY2020Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
244343 usd
CY2020Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
244343 usd
CY2020Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
244343 usd
CY2020Q2 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
244343 usd
CY2020Q2 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
407240 usd
CY2020Q2 FONR Present Value Discount Financing Lease
PresentValueDiscountFinancingLease
180914 usd
CY2020Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
1325870 usd
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y4M24D
CY2020Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P6Y7M6D
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055 pure
CY2020Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.036 pure

Files In Submission

Name View Source Status
0000355019-20-000051-index-headers.html Edgar Link pending
0000355019-20-000051-index.html Edgar Link pending
0000355019-20-000051.txt Edgar Link pending
0000355019-20-000051-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fonar-logo.jpg Edgar Link pending
fonar_10-k.htm Edgar Link pending
fonar_exhibit-21.htm Edgar Link pending
fonar_exhibit-23.htm Edgar Link pending
fonar_exhibit-31.htm Edgar Link pending
fonar_exhibit-32.htm Edgar Link pending
fonr-20200630.xsd Edgar Link pending
fonr_graph.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
fonr-20200630_cal.xml Edgar Link unprocessable
fonr-20200630_def.xml Edgar Link unprocessable
fonr-20200630_lab.xml Edgar Link unprocessable
fonr-20200630_pre.xml Edgar Link unprocessable
fonr-20200630.xml Edgar Link completed
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending